152 related articles for article (PubMed ID: 33207391)
1. Classification system for Helicobacter pylori therapies: Compared and contrasted to traditional infectious disease therapy.
Graham DY; Megraud F
Helicobacter; 2021 Feb; 26(1):e12773. PubMed ID: 33207391
[No Abstract] [Full Text] [Related]
2. Helicobacter pylori antimicrobial resistance during a 5-year period (2013-2017) in northern Spain and its relationship with the eradication therapies.
Cosme A; Torrente Iranzo S; Montes Ros M; Fernández-Reyes Silvestre M; Alonso Galán H; Lizasoain J; Bujanda L
Helicobacter; 2019 Feb; 24(1):e12557. PubMed ID: 30460730
[TBL] [Abstract][Full Text] [Related]
3. [First line eradication treatment of Helicobacter pylori in 2019].
Gressot P; Frossard JL; Grosgurin O; Marti C
Rev Med Suisse; 2019 Oct; 15(667):1854-1858. PubMed ID: 31617972
[TBL] [Abstract][Full Text] [Related]
4. Role of the preliminary susceptibility testing for initial and after failed therapy of Helicobacter pylori infection with levofloxacin, amoxicillin, and esomeprazole.
Marzio L; Coraggio D; Capodicasa S; Grossi L; Cappello G
Helicobacter; 2006 Aug; 11(4):237-42. PubMed ID: 16882326
[TBL] [Abstract][Full Text] [Related]
5. Amoxicillin or tetracycline in bismuth-containing quadruple therapy as first-line treatment for
Bang CS; Lim H; Jeong HM; Shin WG; Choi JH; Soh JS; Kang HS; Yang YJ; Hong JT; Shin SP; Suk KT; Lee JJ; Baik GH; Kim DJ
Gut Microbes; 2020 Sep; 11(5):1314-1323. PubMed ID: 32362221
[TBL] [Abstract][Full Text] [Related]
6. [Sequential therapy regimen for Helicobacter pylori infection in children].
Kalach N; Serhal L; Bergeret M; Spyckerelle C; Dupont C; Raymond J
Arch Pediatr; 2008 Feb; 15(2):200-1. PubMed ID: 18249101
[No Abstract] [Full Text] [Related]
7. Novel and Effective Therapeutic Regimens for
Hu Y; Zhu Y; Lu NH
Front Cell Infect Microbiol; 2017; 7():168. PubMed ID: 28529929
[No Abstract] [Full Text] [Related]
8. [Is antimicrobial susceptibility testing necessary before second-line treatment for Helicobacter pylori infection?].
Nagahara A; Sato N
Nihon Rinsho; 2005 Nov; 63 Suppl 11():421-5. PubMed ID: 16363572
[No Abstract] [Full Text] [Related]
9. [Acquisition of secondary resistance after failure of a first treatment of Helicobacter pylori infection in children].
Kalach N; Benhamou PH; Bergeret M; Gottrand F; Husson MO; Barbier C; Dupont C; Raymond J
Arch Pediatr; 2002 Feb; 9(2):130-5. PubMed ID: 11915493
[TBL] [Abstract][Full Text] [Related]
10. Usefulness of antimicrobial susceptibility in the eradication of Helicobacter pylori.
Cosme A; Montes M; Martos M; Gil I; Mendarte U; Salicio Y; Piñeiro L; Recasens MT; Ibarra B; Sarasqueta C; Bujanda L
Clin Microbiol Infect; 2013 Apr; 19(4):379-83. PubMed ID: 22512623
[TBL] [Abstract][Full Text] [Related]
11. Helicobacter pylori resistance to current therapies.
Smith SM; O'Morain C; McNamara D
Curr Opin Gastroenterol; 2019 Jan; 35(1):6-13. PubMed ID: 30489412
[TBL] [Abstract][Full Text] [Related]
12. Helicobacter pylori antimicrobial resistance and antibiotic consumption in the low-resource Central America setting.
Ortiz V; Estevez-Ordonez D; Montalvan-Sanchez E; Urrutia-Argueta S; Israel D; Krishna US; Romero-Gallo J; Wilson KT; Peek RM; Dominguez R; Morgan DR
Helicobacter; 2019 Aug; 24(4):e12595. PubMed ID: 31111610
[TBL] [Abstract][Full Text] [Related]
13. Antibiotic resistance in Helicobacter pylori.
Alba C; Blanco A; Alarcón T
Curr Opin Infect Dis; 2017 Oct; 30(5):489-497. PubMed ID: 28704226
[TBL] [Abstract][Full Text] [Related]
14. Favorable outcomes of culture-based Helicobacter pylori eradication therapy in a region with high antimicrobial resistance.
Lee JW; Kim N; Nam RH; Lee SM; Kwon YH; Sohn SD; Kim JM; Lee DH; Jung HC
Helicobacter; 2019 Apr; 24(2):e12561. PubMed ID: 30632237
[TBL] [Abstract][Full Text] [Related]
15. Primary clarithromycin resistance to Helicobacter pylori and therapy failure in children: the experience in West Virginia.
Elitsur Y; Lawrence Z; Rüssmann H; Koletzko S
J Pediatr Gastroenterol Nutr; 2006 Mar; 42(3):327-8. PubMed ID: 16540805
[No Abstract] [Full Text] [Related]
16. Comparison of the efficacy of culture-based tailored therapy for Helicobacter pylori eradication with that of the traditional second-line rescue therapy in Korean patients: a prospective single tertiary center study.
Kwon YH; Kim N; Lee JY; Choi YJ; Yoon K; Nam RH; Suh JH; Lee JW; Lee DH
Scand J Gastroenterol; 2016 Mar; 51(3):270-6. PubMed ID: 26452405
[TBL] [Abstract][Full Text] [Related]
17. [Changing patterns of antibiotic resistance of Helicobacter pylori in patients with peptic ulcer disease].
Bang SY; Han DS; Eun CS; Kim JE; Ahn SB; Sohn JH; Jeon YC; Kang JO
Korean J Gastroenterol; 2007 Dec; 50(6):356-62. PubMed ID: 18159172
[TBL] [Abstract][Full Text] [Related]
18. Treatment regimens for Helicobacter pylori infection in children: is in vitro susceptibility testing helpful?
Faber J; Bar-Meir M; Rudensky B; Schlesinger Y; Rachman E; Benenson S; Sirota G; Stankiewic H; Halle D; Wilschanski M
J Pediatr Gastroenterol Nutr; 2005 May; 40(5):571-4. PubMed ID: 15861018
[TBL] [Abstract][Full Text] [Related]
19. Antimicrobial resistance in Helicobacter pylori: current situation and management strategy in Vietnam.
Phan TN; Tran VH; Tran TN; Le VA; Santona A; Rubino S; Paglietti B
J Infect Dev Ctries; 2015 Jul; 9(6):609-13. PubMed ID: 26142670
[TBL] [Abstract][Full Text] [Related]
20. Helicobacter pylori eradication therapy outcome according to clarithromycin susceptibility testing in Japan.
Horie R; Handa O; Ando T; Ose T; Murakami T; Suzuki N; Sendo R; Imamoto E; Itoh Y
Helicobacter; 2020 Aug; 25(4):e12698. PubMed ID: 32368846
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
